A detailed history of Advisor Resource Council transactions in Pfizer Inc stock. As of the latest transaction made, Advisor Resource Council holds 7,901 shares of PFE stock, worth $208,270. This represents 0.08% of its overall portfolio holdings.

Number of Shares
7,901
Holding current value
$208,270
% of portfolio
0.08%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

BUY
$27.7 - $31.39 $218,857 - $248,012
7,901 New
7,901 $228,000
Q1 2024

Apr 19, 2024

SELL
$25.89 - $29.73 $273,320 - $313,859
-10,557 Reduced 51.33%
10,011 $277,000
Q4 2023

Jan 12, 2024

BUY
$26.13 - $33.94 $315,519 - $409,825
12,075 Added 142.18%
20,568 $592,000
Q3 2023

Oct 24, 2023

SELL
$32.09 - $37.51 $46,851 - $54,764
-1,460 Reduced 14.67%
8,493 $281,000
Q2 2023

Jul 13, 2023

SELL
$36.12 - $41.79 $140,434 - $162,479
-3,888 Reduced 28.09%
9,953 $365,000
Q1 2023

Apr 25, 2023

BUY
$39.39 - $51.28 $130,814 - $170,300
3,321 Added 31.57%
13,841 $564,000
Q4 2022

Jan 20, 2023

BUY
$41.75 - $54.5 $3,214 - $4,196
77 Added 0.74%
10,520 $0
Q3 2022

Oct 26, 2022

SELL
$43.76 - $53.42 $1.03 Million - $1.26 Million
-23,628 Reduced 69.35%
10,443 $457,000
Q2 2022

Jul 27, 2022

BUY
$46.53 - $55.17 $44,063 - $52,245
947 Added 2.86%
34,071 $1.79 Million
Q1 2022

Apr 20, 2022

SELL
$45.75 - $56.69 $1.09 Million - $1.36 Million
-23,917 Reduced 41.93%
33,124 $1.72 Million
Q4 2021

Feb 11, 2022

BUY
$41.32 - $61.25 $932,675 - $1.38 Million
22,572 Added 65.48%
57,041 $3.37 Million
Q3 2021

Nov 16, 2021

SELL
$39.25 - $50.42 $526,224 - $675,980
-13,407 Reduced 28.0%
34,469 $1.48 Million
Q2 2021

Aug 19, 2021

BUY
$35.91 - $40.68 $1.65 Million - $1.87 Million
46,002 Added 2454.75%
47,876 $1.87 Million
Q2 2021

Aug 13, 2021

BUY
$35.91 - $40.68 $67,295 - $76,234
1,874 New
1,874 $73,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $148B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Advisor Resource Council Portfolio

Follow Advisor Resource Council and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Resource Council, based on Form 13F filings with the SEC.

News

Stay updated on Advisor Resource Council with notifications on news.